FDA Clarifies Industry Fears of New Inspection Guidance

Drug Industry Daily
A A
FDA officials sought to clarify how the agency’s authority to punish drugmakers for obstructing facility inspections applies to such issues as divulging trade secrets, accessing emails and translating documents into English.

To View This Article:

Login

Subscribe To Drug Industry Daily